BioSpace News Archive

Press Releases

Lilly reports fourth-quarter 2025 financial results and provides 2026 guidance

February 4, 2026
·
20 min read
Press Releases

Final APEX Phase 1b Clinical Results for Kodiak’s KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026

February 4, 2026
·
4 min read
Press Releases

Microbix Presents Molecular Pathology Platform Results

February 4, 2026
·
5 min read
Press Releases

Third Arc Bio Announces $52M Series A Extension to Expand Oncology and Immunology & Inflammation Portfolio

February 4, 2026
·
3 min read
Press Releases

Nature Medicine Publishes Results from the Pivotal DEVOTE Study of High-Dose Regimen of Nusinersen in Spinal Muscular Atrophy

February 4, 2026
·
10 min read
Press Releases

Zevra Therapeutics Presents Positive New Real-World Data on MIPLYFFA® in Patients with Neimann-Pick Disease Type C (NPC) at the 22nd Annual WORLDSymposium™

February 4, 2026
·
8 min read
Press Releases

Axon Neuroscience’s Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant

February 4, 2026
·
6 min read
Press Releases

Spur Therapeutics Presents New Phase 1/2 Data on Its Gene Therapy Candidate in Gaucher Disease at 22nd Annual WORLDSymposium™

February 4, 2026
·
4 min read
Press Releases

Encision Inc. Announces Fiscal 2026 Third Quarter Results

February 4, 2026
·
1 min read
Press Releases

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

February 4, 2026
·
9 min read